Felix Theeuwes

2010

In 2010, Felix Theeuwes earned a total compensation of $1.2M as Chairman and Chief Scientific Officer at DURECT, which was about the same as previous year.

Compensation breakdown

Non-Equity Incentive Plan$229,005
Option Awards$430,724
Salary$483,134
Other$12,720
Total$1,155,583

Theeuwes received $483.1K in salary, accounting for 42% of the total pay in 2010.

Theeuwes also received $229K in non-equity incentive plan, $430.7K in option awards and $12.7K in other compensation.

Rankings

In 2010, Felix Theeuwes' compensation ranked 4,789th out of 10,439 executives tracked by ExecPay. In other words, Theeuwes earned more than 54.1% of executives.

ClassificationRankingPercentile
All
4,789
out of 10,439
54th
Division
Manufacturing
1,715
out of 3,838
55th
Major group
Chemicals And Allied Products
350
out of 921
62nd
Industry group
Drugs
200
out of 680
71st
Industry
Pharmaceutical Preparations
155
out of 481
68th
Source: SEC filing on April 29, 2013.

Theeuwes' colleagues

We found four more compensation records of executives who worked with Felix Theeuwes at DURECT in 2010.

2010

James Brown

DURECT

Chief Executive Officer

2010

Joseph Stauffer

DURECT

Chief Medical Officer

2010

Matthew Hogan

DURECT

Chief Financial Officer

2010

Su Yum

DURECT

Executive Vice President, Pharmaceutical Systems R&D

News

You may also like